Glen Harbor Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.2M Buy
12,096
+588
+5% +$58.4K 0.02% 431
2019
Q2
$1.14M Buy
11,508
+112
+1% +$10.7K 0.02% 448
2019
Q1
$1.26M Buy
11,396
+2,772
+32% +$290K 0.03% 416
2018
Q4
$793K Buy
8,624
+1,232
+17% +$125K 0.02% 481
2018
Q3
$814K Buy
+7,392
New +$770K 0.02% 533

Other funds holding PRAH

Glen Harbor Capital Management's PRAH Position: Q3 2019 in Review

Glen Harbor Capital Management increased its PRA Health Sciences, Inc. (PRAH) stake by 5.1% in Q3 2019, buying an estimated $58.4K and bringing the position to 12,096 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #431.

Glen Harbor Capital Management first reported a position in PRAH in Q3 2018 and has held it in 5 quarters since. The position peaked at $1.26M in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Glen Harbor Capital Management held 12,096 shares of PRA Health Sciences, Inc. worth $1.2M as of Q3 2019.
  • Glen Harbor Capital Management bought 588 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $58.4K.
  • PRA Health Sciences, Inc. made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #431 holding.
  • Glen Harbor Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and has held it in 5 quarters since.
  • Glen Harbor Capital Management's PRA Health Sciences, Inc. position peaked at $1.26M in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.